State Street Corp Sarepta Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 4,270,766 shares of SRPT stock, worth $521 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,270,766

Previous 4,141,793 3.11%

Holding current value

$521 Million

Previous $654 Million 18.49%

% of portfolio

0.02%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $16 Million - $20.2 Million	128,973 Added 3.11%	4,270,766 $533 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $229 Million - $331 Million	2,019,302 Added 95.14%	4,141,793 $654 Million
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $25.9 Million - $39.1 Million	-276,587 Reduced 11.53%	2,122,491 $275 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $27.8 Million - $51.6 Million	413,502 Added 20.83%	2,399,078 $231 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $7.36 Million - $8.88 Million	71,844 Added 3.75%	1,985,576 $241 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $14.9 Million - $22 Million	139,756 Added 7.88%	1,913,732 $219 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $19.7 Million - $26.2 Million	-167,768 Reduced 8.64%	1,773,976 $245 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $681,914 - $893,330	6,761 Added 0.35%	1,941,744 $252 Million
Q3 2022 Nov 15, 2022	SELL	$75.71 - $119.24 $28.9 Million - $45.5 Million	-381,500 Reduced 16.47%	1,934,983 $214 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $16.2 Million - $22.9 Million	258,808 Added 12.58%	2,316,483 $174 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $12.3 Million - $17.6 Million	194,320 Added 10.43%	2,057,675 $161 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $5.51 Million - $7.08 Million	71,261 Added 3.98%	1,863,355 $168 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $6.98 Million - $9.78 Million	105,749 Added 6.27%	1,792,094 $166 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $23.9 Million - $29.9 Million	-344,960 Reduced 16.98%	1,686,345 $131 Million
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $12.4 Million - $29.1 Million	172,233 Added 9.26%	2,031,305 $151 Million
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $5.05 Million - $7.18 Million	-40,180 Reduced 2.12%	1,859,072 $317 Million
Q3 2020 Nov 10, 2020	BUY	$127.12 - $172.34 $8.05 Million - $10.9 Million	63,307 Added 3.45%	1,899,252 $267 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $20.4 Million - $37.6 Million	-218,849 Reduced 10.65%	1,835,945 $294 Million
Q1 2020 May 11, 2020	BUY	$82.38 - $131.64 $169 Million - $270 Million	2,054,794 New	2,054,794 $201 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.7B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Sarepta Therapeutics, Inc. Transaction History